Lupin Receives FDA Approval for Levetiracetam Tablets

Lupin said that the company’s U.S. subsidiary, Lupin Pharmaceuticals Inc. received the final approval for the company’s ANDA for Levetiracetam tablets of 250 mg, 500 mg, 750 mg, and 1000 mg from the US FDA.
RTTNews